These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 17525050)

  • 1. In vitro interaction of micafungin and fluconazole against Candida.
    Rodríguez MM; Ruiz M; Pastor FJ; Quindós G; Carrillo A; Guarro J
    J Antimicrob Chemother; 2007 Jul; 60(1):188-90. PubMed ID: 17525050
    [No Abstract]   [Full Text] [Related]  

  • 2. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
    Messer SA; Diekema DJ; Boyken L; Tendolkar S; Hollis RJ; Pfaller MA
    J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficiency of the benzothiazole APB, the echinocandin micafungin, and amphotericin B in fluconazole-resistant Candida albicans and Candida dubliniensis.
    Melkusová S; Bujdáková H; Volleková A; Myoken Y; Mikami Y
    Pharmazie; 2004 Jul; 59(7):573-4. PubMed ID: 15296100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micafungin activity against Candida bloodstream isolates: effect of growth medium and susceptibility testing method.
    Pai MP; Jones AL; Mullen CK
    Diagn Microbiol Infect Dis; 2007 May; 58(1):129-32. PubMed ID: 17240112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of voriconazole combined with micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solani.
    Heyn K; Tredup A; Salvenmoser S; Müller FM
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5157-9. PubMed ID: 16304192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal susceptibility of epigallocatechin 3-O-gallate (EGCg) on clinical isolates of pathogenic yeasts.
    Park BJ; Park JC; Taguchi H; Fukushima K; Hyon SH; Takatori K
    Biochem Biophys Res Commun; 2006 Aug; 347(2):401-5. PubMed ID: 16831406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro effects of micafungin against Candida biofilms on polystyrene and central venous catheter sections.
    Seidler M; Salvenmoser S; Müller FM
    Int J Antimicrob Agents; 2006 Dec; 28(6):568-73. PubMed ID: 17101265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of disc diffusion and microdilution methods in susceptibility testing of micafungin against Candida species.
    Ramírez M; Serrano MC; Castro C; López E; Almeida C; Fernández A; Romero A; Martín-Mazuelos E
    J Antimicrob Chemother; 2006 Oct; 58(4):861-3. PubMed ID: 16916868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of micafungin combined with itraconazole against Candida spp.
    Mariné M; Serena C; Pastor J; Quindós G; Carrillo AJ; Guarro J
    Int J Antimicrob Agents; 2007 Nov; 30(5):463-5. PubMed ID: 17698327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micafungin: a new echinocandin antifungal.
    Joseph JM; Jain R; Danziger LH
    Pharmacotherapy; 2007 Jan; 27(1):53-67. PubMed ID: 17192162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired resistance to echinocandins in Candida albicans: case report and review.
    Baixench MT; Aoun N; Desnos-Ollivier M; Garcia-Hermoso D; Bretagne S; Ramires S; Piketty C; Dannaoui E
    J Antimicrob Chemother; 2007 Jun; 59(6):1076-83. PubMed ID: 17468115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Killing kinetics of caspofungin, micafungin, and amphotericin B against Candida guilliermondii.
    Cantón E; Pemán J; Sastre M; Romero M; Espinel-Ingroff A
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2829-32. PubMed ID: 16870779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal susceptibility testing of micafungin against Candida glabrata isolates.
    Oliveira ER; Fothergill A; Kirkpatrick WR; Patterson TF; Redding SW
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Apr; 105(4):457-9. PubMed ID: 18329581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid flow-cytometric susceptibility testing of Candida species.
    Rudensky B; Broidie E; Yinnon AM; Weitzman T; Paz E; Keller N; Raveh D
    J Antimicrob Chemother; 2005 Jan; 55(1):106-9. PubMed ID: 15546969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candida albicans and Candida dubliniensis respond differently to echinocandin antifungal agents in vitro.
    Jacobsen MD; Whyte JA; Odds FC
    Antimicrob Agents Chemother; 2007 May; 51(5):1882-4. PubMed ID: 17307974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro antifungal activity of FK463, a new water-soluble echinocandin-like lipopeptide.
    Mikamo H; Sato Y; Tamaya T
    J Antimicrob Chemother; 2000 Sep; 46(3):485-7. PubMed ID: 10980180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro synergistic interaction between amphotericin B and micafungin against Scedosporium spp.
    Yustes C; Guarro J
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3498-500. PubMed ID: 16048969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micafungin: a new echinocandin.
    Chandrasekar PH; Sobel JD
    Clin Infect Dis; 2006 Apr; 42(8):1171-8. PubMed ID: 16575738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of three new triazoles and one echinocandin against Candida bloodstream isolates from cancer patients.
    Laverdiere M; Hoban D; Restieri C; Habel F
    J Antimicrob Chemother; 2002 Jul; 50(1):119-23. PubMed ID: 12096017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro interaction of posaconazole and caspofungin against clinical isolates of Candida glabrata.
    Oliveira ER; Fothergill AW; Kirkpatrick WR; Coco BJ; Patterson TF; Redding SW
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3544-5. PubMed ID: 16048980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.